Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1379.6000 17.40 (1.28%)
NSE Jul 07, 2026 15:31 PM
Volume: 138.0K
 

logo
Rubicon Research Ltd.
13 Nov 2025
1379.60
1.28%

Outperformance across metrics; stellar start to the post-IPO phase

buy
by Motilal Oswal
Target: 780
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
 
Rubicon Research Ltd. has an average target of 1160.00 from 5 brokers.
More from Rubicon Research Ltd.
Recommended
India's EV market grows beyond the early winners
The Baseline | 07 Jul 2026, 05:53PM
Market closes flat, dragged down by losses in metal & realty stocks
Trendlyne Marketwatch | 07 Jul 2026, 03:56PM
Primary market focus turns to listings, with eight companies set to debut
| 06 Jul 2026, 05:53PM